# Verastem, Inc. (VSTM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VSTM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 58.75M | $ -71.26M | $ -96.03M | $ 84.33M | $ 49.99M |
| 2025 | $ 31.65M | $ -214.48M | $ -142.17M | $ 87.17M | $ 57.20M |
| 2024 | $ 10.51M | $ -137.31M | $ -110.15M | $ 42.25M | $ -28.89M |
| 2023 | $ 0 | $ -94.47M | $ -93.49M | $ 41.56M | $ 57.37M |
| 2022 | $ 2.90M | $ -82.46M | $ -71.13M | $ 27.07M | $ 47.39M |
| 2021 | $ 2.44M | $ -84.63M | $ -63.83M | $ 3.18M | $ 87.56M |
| 2020 | $ 112.76M | $ -86.28M | $ -44.94M | $ 22.54M | $ 115.27M |
| 2019 | $ 22.53M | $ -192.59M | $ -178.81M | $ 107.53M | $ 7.17M |
| 2018 | $ 35.29M | $ -95.66M | $ -129.46M | $ 120.45M | $ 124.30M |
| 2017 | $ 0 | $ -91.34M | $ -77.20M | $ 14.83M | $ 57.68M |
| 2016 | $ 0 | $ -50.14M | $ -40.62M | $ 0 | $ 72.30M |
| 2015 | $ 0 | $ -81.24M | $ -64.26M | $ 0 | $ 102.47M |
| 2014 | $ 0 | $ -75.41M | $ -55.58M | $ 0 | $ 88.77M |
| 2013 | $ 0 | $ -58.60M | $ -37.49M | $ 0 | $ 117.45M |
| 2012 | $ 0 | $ -46.18M | $ -32.63M | $ 0 | $ 90.47M |
| 2011 | $ 0 | $ -20.10M | $ -16.04M | $ 0 | $ 55.38M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.69 |
| Liabilities / Eq | 3.13 |
| Current Ratio | 2.25 |

## Other views

- [Metrics](https://sponda.capital/en/VSTM.md)
- [Charts](https://sponda.capital/en/VSTM/charts.md)
- [Compare](https://sponda.capital/en/VSTM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.